// App-Quantinova.ai

11566 2014 AHA : Beyond LDL Cholesterol: Carriers of the PCSK9 R46L Variant Are Characterized by an Anti-Atherogenic Lipoprotein Profile Assessed by Nuclear Magnetic Resonance Spectroscopy

Researchers

Presenter

  • S. Matthijs Boekholdt

Principal Investigators

  • G. Kees Hovingh

  • John JP Kastelein

  • Nicholas J Wareham

  • Kay-Tee Khaw

Medical Centers

  • Ctr de recherche de -IUCPQ, Quebec, QC, Canada

  • University of Cambridge, Cambridge, United Kingdom

  • Academic Medical Center, Amsterdam, Netherlands

Locations

  • Canada

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diabetes

  • Solid malignancies

Biomarkers

  • Cholesterol

  • Proprotein convertase subtilisin/kexin type 9

  • Enzyme lipoprotein-associated phospholipase A2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved